Delivery Order SPE2D021DA002-SPE2D326F5242
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,091.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies on January 7, 2026, with completion scheduled for January 8, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack unit). The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The contract, executed on January 29, 2026, with an ultimate completion date of January 30, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector medication (two-pack units) with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order was issued without set-aside designation, reflecting the vendor's competitive capability in unrestricted federal procurement. The award was made under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $4,007.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs. The award was issued on January 13, 2026, with an ultimate completion date of January 14, 2026, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, represents a standalone procurement without set-aside designation, demonstrating the contractor's...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,219.75 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The contract, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was awarded on a firm fixed-price basis without set-aside designation, demonstrating the contractor's competitive...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F5242Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,401.75 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector 2-packs on February 2, 2026, with completion due by February 3, 2026. This firm fixed-price delivery order was issued without set-aside designation, allowing the award to compete on an unrestricted basis. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee based on its established capability to supply critical pharmaceutical products to Department of Defense medical facilities. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across military healthcare operations worldwide. The underlying PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a base period of 30 months followed by three optional 30-month periods. The delivery order for emergency epinephrine auto-injectors exemplifies the diverse therapeutic categories and critical medical consumables that the company supplies to support Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 2/1/26 |